DIADIA0.56%
SPYSPY0.25%
QQQQQQ1.50%
Trending
Top trending tickerMUMU7.09%
QQQQQQ1.50%
SNDKSNDK9.60%
SPYSPY0.25%
ASTSASTS2.58%
AAPLAAPL1.72%
SOXLSOXL13.36%
KORUKORU25.66%
APLDAPLD4.10%
SOFISOFI4.18%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolGRALnews
Exchange: NASDAQ·Updated 07:55 PM EDT

GRAL News

News
all
press releases
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026 GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026PR NewswireSUNNYVALE, Calif., Oct. 5, 2026GRAIL to Present Six Abstracts at the Early Detection of Cancer Conference...
PR Newswire
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026 GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026PR NewswireSUNNYVALE, Calif., Oct. 5, 2026GRAIL to Present Six Abstracts at the Early Detection of Cancer Conference...
PR Newswire
More News
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’
Martin Shkreli, who said he was short KOD before the readout, questioned Zenkuda’s edge over Eylea and dismissed the added IL-6 targeting in KSI-501.
Stocktwits
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Five smaller stocks with market caps above $100 million beat MRNA’s monthly gain: INDP rose 249%, CYPH 124%, MNOV 85%, GRAL 58% and SRZN 53%.
Stocktwits
These Stocks are Refusing to Cool Off
The closing bell is shaping up to be anything but quiet for these names that stand out as the session heads toward the finish. Greenland Energy Company (NASDAQ:GLND), NeOnc Technologies Holdings (NASDAQ:NTHI), GRAIL (NASDAQ:GRAL), Warby Parker (NYSE:WRBY), Montauk Renewables (NASDAQ:MNTK), Ginkgo Bioworks Holdings (NYSE:DNA), and CareDx (NASDAQ:CDNA).
24-7 Market News
GRAIL's Galleri Cancer Test Clears FDA Panel On Safety, Narrowly Backed On Effectiveness: GRAL Stock In Focus
An FDA advisory panel voted unanimously that GRAIL's Galleri multi-cancer blood test is safe and backed its effectiveness 6-4.
Stocktwits
GRAL Stock Clocks Best Day In Over 1.5 Years — FDA Papers Lift Galleri Approval Hopes
Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on Sept. 23 to discuss Grail’s application seeking approval of its cancer detection test.
Stocktwits
FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week
Merck, Mirum, Incyte and Grail are in focus this week as investors await key FDA decisions and a regulatory review involving treatments for lung disease, a rare bone disorder and cancer detection.
Stocktwits
GRAIL Q2 2026 Earnings Call: Complete Transcript
On Wednesday, GRAIL (NASDAQ:GRAL) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial dataread more...
Benzinga
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire SUNNYVALE, Calif., Sept. 3, 2026 SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission...
PR Newswire
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif., Aug. 31, 2026 MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...
PR Newswire

Advertisement|Remove ads.